Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Journal of Global Pharma Technology
Raisa A. Aringazina
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Comorbidity of the Metabolic Syndrome: Hyperuricemia, Gallstone Disease, Hormonal Disorders Raisa A. Aringazina
Journal of Global Pharma Technology Volume 11 Issue 04 (2019) April 2019
Publisher : Journal of Global Pharma Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (574.932 KB)

Abstract

This article presents relationships between metabolic syndrome and gallstone disease, hyperuricemia, hormonal disorders and point out the most relevant picture for today. In the review the general pathogenetic mechanism of endothelial dysfunction formation in metabolic syndrome and hyperuricemia is revealed and described. Shown, that hyperuricemia is a marker of the metabolic syndrome. The symptoms of metabolic syndrome increase with increasing levels of hyperuricemia. The review found that it is obesity and insulin resistance are common leading risk factors for progression metabolic syndrome and gallstone disease. No association between gallstone disease and dyslipidemia unlike metabolic syndrome. Obesity is a common factor in the relationship between metabolic syndrome, gallstone disease and hormonal disorders. Insulin resistance is a common factor metabolic syndrome and polycystic ovary syndrome, the leading factor in the course of metabolic syndrome in menopause, hypopituitarism, and gallstone disease. Also, insulin resistance is a common factor in the comorbidity of gallstone disease and postmenopausal conditions. Obesity and insulin resistance are common factors of metabolic syndrome and benign prostate hyperplasia. Keywords: Metabolic syndrome, Uric acid, Gallstone disease, Hyperuricemia, Hormonal disorders.
Co-Authors